Psoriasis treatment does not impair the immunogenicity of ChAOx1-S[recombinant] COVID-19 vaccination

MLA

Luis Puig. “Psoriasis Treatment Does Not Impair the Immunogenicity of ChAOx1-S[Recombinant] COVID-19 Vaccination.” British Journal of Dermatology, vol. 188, Nov. 2022, pp. 163–65. EBSCOhost, https://doi.org/10.1093/bjd/ljac081.

APA

Luis Puig. (2022). Psoriasis treatment does not impair the immunogenicity of ChAOx1-S[recombinant] COVID-19 vaccination. British Journal of Dermatology, 188, 163–165. https://doi.org/10.1093/bjd/ljac081

Chicago

Luis Puig. 2022. “Psoriasis Treatment Does Not Impair the Immunogenicity of ChAOx1-S[Recombinant] COVID-19 Vaccination.” British Journal of Dermatology 188 (November): 163–65. doi:10.1093/bjd/ljac081.